Andere Kunden interessierten sich auch für
![ADVANCED DISCONNECTING INTERVENTIONS IN PORTAL HYGIENE SURGERY]( "ADVANCED DISCONNECTING INTERVENTIONS IN PORTAL HYGIENE SURGERY")
ADVANCED DISCONNECTING INTERVENTIONS IN PORTAL HYGIENE SURGERY42,99 €![Trombose portal não tumoral em cirrose]( "Trombose portal não tumoral em cirrose")
Trombose portal não tumoral em cirrose36,99 €![Assessment of the risk of recurrence after a first episode of thrombosis]( "Assessment of the risk of recurrence after a first episode of thrombosis")
Assessment of the risk of recurrence after a first episode of thrombosis29,99 €![Management of abdominal thrombosis in non-cirrhotic patients:]( "Management of abdominal thrombosis in non-cirrhotic patients:")
Management of abdominal thrombosis in non-cirrhotic patients:29,99 €![Portal hypertension and haemorrhage]( "Portal hypertension and haemorrhage")
Portal hypertension and haemorrhage26,99 €![Heparin-induced thrombocytopenia in the intensive care setting]( "Heparin-induced thrombocytopenia in the intensive care setting")
Heparin-induced thrombocytopenia in the intensive care setting29,99 €![MONDOR DISEASE IN THE COURSE OF COVID-19.]( "MONDOR DISEASE IN THE COURSE OF COVID-19.")
MONDOR DISEASE IN THE COURSE OF COVID-19.29,99 €
Non-tumor portal thrombosis (PT) is a frequent complication of cirrhosis. Its treatment is essentially based on anticoagulation which, in a context of haemostasis disorders, can lead to bleeding complications.Moreover, it has not been proven that revascularization of the portal trunk has an impact on survival and on the evolution of the underlying liver disease.The objectives of this work were first to evaluate the prevalence, the risk factors and the clinical impact of PT in cirrhotic patients. Secondly, to discuss the interest of anti-coagulant treatment.